title: Murine acid alpha-glucosidase: cell-specific mRNA differential expression during development and maturation.
abstract: Acid alpha-glucosidase (GAA) cleaves the alpha1-4 and alpha1-6 glycosidic linkages of glycogen and related alpha-glucosyl substrates within lysosomes. Its deficiency results in glycogen storage disease type II (GSDII) variants including Pompe disease. To gain insight into the tissue patterns of involvement by glycogen storage in GSDII, GAA mRNA expression in mouse tissues was evaluated by Northern blot and in situ hybridization analyses. Extensive temporal and spatial variation of GAA mRNA was observed. During preterm maturation, GAA mRNA levels of whole mice progressively increased as assessed by Northern analysis. By in situ hybridization with GAA antisense mRNA, low signals were detected in most tissues throughout gestation. However, increased expression in specific cell types of different tissues was observed beginning at 16 days post coitum in developing brain neurons, primitive inner ear cells, and seminiferous tubular epithelium. In adult mice, whole-organ GAA mRNA levels were highest in brain, moderate in heart, liver, and skeletal muscle, and lowest in the series kidney > lung > testis > spleen. By in situ hybridization, the highest-intensity signals were in neurons of the central and peripheral nervous systems whereas neuroglial cells had only low-level signal. Signals of moderate intensity were in cardiomyocytes whereas low signals were in hepatocytes and skeletal muscle myocytes and very low in cells of the lungs, thymus, pancreas, spleen, and adrenal glands. However, testicular Sertoli cells and kidney tubular epithelial cells had significant signals even though surrounding cells had very low signals. The discrete temporal and spatial variations of GAA mRNA during development indicate different physiological roles for this enzyme in various cell types and developmental stages.
authors.affiliation: Division of Human Genetics, Children's Hospital Medical Center, Cincinnati, Ohio, USA. eponce@chmcc.org
authors.forename: E
authors.initials: E
authors.lastname: Ponce
authors.forename: D P
authors.initials: DP
authors.lastname: Witte
authors.forename: R
authors.initials: R
authors.lastname: Hirschhorn
authors.forename: M L
authors.initials: ML
authors.lastname: Huie
authors.forename: G A
authors.initials: GA
authors.lastname: Grabowski
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D002490:Central Nervous System / Q000201:enzymology; D004622:Embryo, Mammalian; D018507:Gene Expression Regulation, Developmental; D005087:Glucan 1,4-alpha-Glucosidase / Q000235:genetics*; D017403:In Situ Hybridization; D008099:Liver / Q000201:enzymology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D018482:Muscle, Skeletal / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D009474:Neurons / Q000201:enzymology; D009928:Organ Specificity; D016372:RNA, Antisense / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis*; D013997:Time Factors; D000520:alpha-Glucosidases / Q000235:genetics*
chemical_list: D016372:RNA, Antisense; D012333:RNA, Messenger; D000520:alpha-Glucosidases; D005087:Glucan 1,4-alpha-Glucosidase